Research finds drug prices increased without adding new clinical benefits
The net prices of five drugs included in a new study from the Institute for Clinical and Economic Review increased without clinical justification in 2023. These increases led to $815 million incremental added costs for U.S. payers.
Related News Articles
Blog
Recent analyses of national health spending have again placed hospitals at the center of the affordability debate. A recent Kaiser Family Foundation brief…
Perspective
From birth to death, from critical injuries to elective surgeries, from crisis and disaster to community food banks and health improvement initiatives —…
Headline
America’s hospitals and health systems are deeply committed to providing high-quality, accessible and affordable care, AHA President and CEO Rick Pollack March…
Perspective
A hospital patient from the 1990s would likely marvel at the pace of progress in health care just a generation later. America’s hospitals and health systems…
Headline
The AHA March 11 released the latest edition of its annual Costs of Caring report, highlighting how hospitals and health systems continue to face increases in…
Headline
The AHA March 3 urged the Health Resources and Services Administration to take immediate action to stop a new Novo Nordisk policy from taking effect…